Mummified Cells are a Common Finding in Cutaneous Hodgkin Lymphoma and Can Be Used as a Diagnostic Clue.


Journal

The American Journal of dermatopathology
ISSN: 1533-0311
Titre abrégé: Am J Dermatopathol
Pays: United States
ID NLM: 7911005

Informations de publication

Date de publication:
Jan 2020
Historique:
pubmed: 7 6 2019
medline: 3 6 2020
entrez: 7 6 2019
Statut: ppublish

Résumé

Specific cutaneous involvement in Hodgkin lymphoma is rare. In cutaneous lesions, the diagnosis is usually based on the recognition of diagnostic Reed-Sternberg cells and its variants. In nodal Hodgkin lymphoma, so-called mummified cells (cells with condensed cytoplasm and pyknotic eosinophilic or basophilic nuclei) are often seen. They are sometimes conspicuous and easy to recognize, thus serving as a clue to the diagnosis. Our objective was to study cases of cutaneous Hodgkin lymphoma to identify the occurrence of mummified cells. We studied 12 patients (4 women and 8 men; age range 23-80 years). In 6 patients, cutaneous and extracutaneous disease was identified almost simultaneously; in 4 patients, lymph node disease preceded cutaneous involvement; and in the remaining 2 patients, the skin lesions were the presenting sign, whereas lymph node involvement occurred later. Histopathological, immunohistochemical, and molecular-genetic studies, including rearrangements for TCR, IgH genes, and PCR for EBV, were performed. Cutaneous biopsy specimens revealed either a multinodular or diffuse infiltrate, included small lymphocytes, eosinophils, plasma cells, and macrophages, but in all cases, diagnostic Reed-Sternberg cells and its variants were identified. Mummified cells were detected in 9 cases, either as occasional scattered mummified cells often requiring a search (6 cases) or being conspicuous, grouped and therefore easily identified (3 cases). Immunohistochemically, in all 7 cases studied, mummified cells were positive for both CD30 and CD15. It is concluded that mummified cells are encountered in a majority of cases of cutaneous Hodgkin lymphoma.

Identifiants

pubmed: 31169526
doi: 10.1097/DAD.0000000000001445
pii: 00000372-202001000-00005
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-28

Références

Smith JL Jr, Butler JJ. Skin involvement in Hodgkin's disease. Cancer. 1980;45:354–361.
White RM, Patterson JW. Cutaneous involvement in Hodgkin's disease. Cancer. 1985;55:1136–1145.
Tassies D, Sierra J, Montserrat E, et al. Specific cutaneous involvement in Hodgkin's disease. Hematol Oncol. 1992;10:75–79.
Moretti S, Pimpinelli N, Di Lollo S, et al. In situ immunologic characterization of cutaneous involvement in Hodgkin's disease. Cancer. 1989;63:661–666.
Sioutos N, Kerl H, Murphy SB, et al. Primary cutaneous Hodgkin's disease. Unique clinical, morphologic, and immunophenotypic findings. Am J Dermatopathol. 1994;16:2–8.
Cerroni L, Beham-Schmid C, Kerl H. Cutaneous Hodgkin's disease: an immunohistochemical analysis. J Cutan Pathol. 1995;22:229–235.
van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia. 2003;17:2257–2317.
Kazakov DV, Nemcova J, Mikyskova I, et al. Absence of Epstein-Barr virus, human papillomavirus, and simian virus 40 in patients of central european origin with lymphoepithelioma-like carcinoma of the skin. Am J Dermatopathol. 2007;29:365–369.
Watzinger F, Suda M, Preuner S, et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol. 2004;42:5189–5198.
Svajdler M Jr, Kaspirkova J, Mezencev R, et al. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population. Neoplasma. 2016;63:107–114.
Sternberg C Ueber eine eigenartige unter dem Bilde der Pseudoleukaemie verlaufende Tuberculose des lymphatischen Apparates. Z Heilkunde. 1898;19:21–90.
Reed DM. On the pathological changes in Hodgkin's diease, with especial reference to its relation to tuberculosis. Johns Hopkins Hosp Rep. 1902;10:133–196.
Jackson H, Parker F. Hodgkin's disease II. Pathology. N Engl J Med. 1944;231:35–44.
Cross RM. Hodgkin's disease: histological classification and diagnosis. J Clin Pathol. 1969;22:165–182.
Kodousek R, Tichá V, Tichý M. Selective monocellular necrosis of Hodgkin's/Reed-Sternberg cells and their immunoreactivity to human serum antinuclear antibodies in NS- and MC-types of malignant lymphogranuloma. Neoplasma. 1992;39:205–210.
Lorenzen J, Thiele J, Fischer R. The mummified Hodgkin cell: cell death in Hodgkin's disease. J Pathol. 1997;182:288–298.
Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257.
Payne CM, Bernstein C, Bernstein H. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leuk Lymphoma. 1995;19:43–93.
Gru AA, Lu D. Concurrent malignant melanoma and cutaneous involvement by classical Hodgkin lymphoma (CHL) in a 63 year-old man. Diagn Pathol. 2013;8:135.

Auteurs

Liubov Kastnerova (L)

Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University, Pilsen, Czech Republic.
Bioptical Laboratory, Pilsen, Czech Republic.

Irena E Belousova (IE)

Department of Dermatology, Medical Military Academy, Saint Petersburg, Russia.

Ladislav Hadravsky (L)

Department of Pathology, General University Hospital, 1st Faculty of Medicine, Charles University in Prague, Czech Republic.

Helmut Kerl (H)

Department of Dermatology, Medical University Hopsital, Graz, Austria.

Lorenzo Cerroni (L)

Department of Dermatology, Medical University Hopsital, Graz, Austria.

Katrin Kerl (K)

Dermatopathology Unit, Department of Dermatology, Zurich University Hospital, Zurich, Switzerland; and.

Ludmila Boudova (L)

Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University, Pilsen, Czech Republic.
Bioptical Laboratory, Pilsen, Czech Republic.

Pavel Jindra (P)

Deparment of Hematooncology, Medical Faculty Hospital, Pilsen, Czech Republic.

Katerina Cerna (K)

Bioptical Laboratory, Pilsen, Czech Republic.

Michal Michal (M)

Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University, Pilsen, Czech Republic.
Bioptical Laboratory, Pilsen, Czech Republic.

Dmitry V Kazakov (DV)

Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University, Pilsen, Czech Republic.
Bioptical Laboratory, Pilsen, Czech Republic.
Dermatopathology Unit, Department of Dermatology, Zurich University Hospital, Zurich, Switzerland; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH